Home example 2 - Pharmamarketeer

overig

Nintedanib awarded Promising Innovative Medicine designation for malignant pleural mesothelioma

Nintedanib has been designated a Promising Innovative Medicine for the treatment of malignant pleural mesothelioma (MPM) by the UK Medicine and Healthcare Products Regulatory Agency (MHRA).

Drug Discovery Today

2 x gelezen

wet- en regelgeving

U.S. top court rejects Helsinn over anti-nausea drug patent in win for Teva

The U.S. Supreme Court on Tuesday refused to revive Swiss drug company Helsinn Healthcare S.A.’s patent on the lucrative anti-nausea drug Aloxi in a victory for Teva Pharmaceutical Industries, which launched a...

Reuters Health

2 x gelezen

onderzoek

Eli Lilly’s diabetes treatment meets main goal in two late-stage studies

Eli Lilly and Co said on Tuesday its experimental diabetes treatment was shown to be as effective as the drugmaker’s Humalog medicine in two late-stage studies.

Pharmamarketeer

2 x gelezen

marketing

[MarTech] Desmyttere (Husky): ‘Marketing werkt nu nog vaak te veel in silo’s’

Peter Desmyttere is een marketeer met 25 jaar ervaring in marketing planning. Hij is de founder van Husky – een digitale marketingplanner die steeds vaker Excel-files vervangt – en een van de keynotes op...

MarketingTribune

2 x gelezen

onderzoek

Insulin drug could treat glioblastoma

A research team from the University of Georgia’s Regenerative Bioscience Center has found that a compound molecule used for drug delivery of insulin could be used to treat glioblastoma, an aggressive, usually...

News-Medical.Net

2 x gelezen

wet- en regelgeving

FDA warns three Hepatitis C drugs may worsen liver function in some rare cases

The FDA has warned that three Hepatitis C (HCV) drugs made by AbbVie, Gilead and MSD are worsening liver function and causing liver failure in some patients. The US regulator said it has identified 63 cases in which HCV...

InPharm.com

2 x gelezen

wet- en regelgeving

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

The Trump administration has been trumpeting a huge increase in FDA generic drug approvals the past two years, the result of its actions to streamline a cumbersome process and combat anti-competitive practices.

News-Medical.Net

2 x gelezen

overig

NICE rejects Eisai’s Halaven in earlier setting for metastatic breast cancer

NICE has published its decision not to recommend Eisai’s Halaven (eribulin) in the treatment of locally advanced or metastatic breast cancer after one prior chemotherapy regimen, but the manufacturer has been keen to...

Pharmafile

2 x gelezen

overig

Bayer contraceptive implant public backlash brings results

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with women how had the device implanted suggesting that they were had not been made aware of the risks.

Pharmafile

2 x gelezen

overig

Ovarian cancer rates set to rise by 55%

Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type of cancer are set to greatly increase globally by nearly 55% over the next 20 years.

Pharmafile

2 x gelezen

Latest articles

Nintedanib awarded Promising Innovative Medicine designation for malignant pleural mesothelioma

U.S. top court rejects Helsinn over anti-nausea drug patent in win for Teva

Eli Lilly’s diabetes treatment meets main goal in two late-stage studies

[MarTech] Desmyttere (Husky): ‘Marketing werkt nu nog vaak te veel in silo’s’

Insulin drug could treat glioblastoma

FDA warns three Hepatitis C drugs may worsen liver function in some rare cases

Trump administration salutes parade of generic drug approvals, but hundreds aren’t for sale

NICE rejects Eisai’s Halaven in earlier setting for metastatic breast cancer

Bayer contraceptive implant public backlash brings results

Ovarian cancer rates set to rise by 55%

Wekelijkse highlights per e-mail

Algemene informatie